Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RIGL - Rigel Pharmaceuticals: No Respect With Little Justification Worth Considering A Buy

RIGL - Rigel Pharmaceuticals: No Respect With Little Justification Worth Considering A Buy

Rigel Pharmaceuticals Inc.

2024-04-29 07:00:00 ET

Summary

  • Rigel Pharmaceuticals has multiple approved agents and a modest pipeline of developmental projects.
  • The company has a stable financial position with growing sales and a new product in its stable.
  • Rigel Pharmaceuticals faces both strengths and risks in the competitive pharmaceutical industry.

...

For further details see:

Rigel Pharmaceuticals: No Respect With Little Justification, Worth Considering A Buy
Stock Information
Company Name: Rigel Pharmaceuticals Inc.
Stock Symbol: RIGL
Market: NASDAQ
Website: rigel.com
Menu
RIGL RIGL Quote RIGL Short RIGL News RIGL Articles RIGL Message Board
Get RIGL Alerts

News, Short Squeeze, Breakout and More Instantly...